Search

everythinglearnresearchcommunity

for

Search:↓

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Finasteride effectively treats baldness but may cause sexual side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Lespedeza cuneata extract may help treat enlarged prostate.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Hair loss can be an early sign of prostate enlargement.

Stopping finasteride improves sperm quality but not semen volume in young men.

Finasteride significantly reduces fertility in male rats.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A new compound was made that might help treat diseases related to male hormones.